OMERS Administration Corp’s ProKidney PROK Stock Holding History

OMERS Administration Corp’s Portfolio PROK Stock Details PROK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-67,900	Closed	-$122K	–	1090
2026 Q1	$122K	Sell	67,900 -56,500	-45%	-$120K	﹤0.01%	987
2025 Q4	$279K	Buy	+124,400	New	+$327K	﹤0.01%	829
2021 Q4	–	Sell	-40,000	Closed	-$392K	–	421
2021 Q3	$392K	Hold	40,000	–	–	0.01%	191
2021 Q2	$405K	Buy	+40,000	New	+$404K	0.01%	239

Other funds holding PROK

SCM

Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bleichroeder LP New York $559M AUM 83.7% 1-Year Est. Return

HWAM

Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return

AGP

Artia Global Partners Miami, Florida $542M AUM 206.64% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

OMERS Administration Corp's PROK Position: Q2 2026 in Review

OMERS Administration Corp sold out of ProKidney (PROK) in Q2 2026, closing a stake of 67,900 shares — an estimated $122K sold.

OMERS Administration Corp first reported a position in PROK in Q2 2021 and held it in 4 quarters. The position peaked at $405K in Q2 2021. 71 funds tracked by Wall St. Rank hold PROK as of Q2 2026.

OMERS Administration Corp reported no remaining ProKidney position as of Q2 2026 after selling out during the quarter.
OMERS Administration Corp sold 67,900 ProKidney shares in Q2 2026, an estimated $122K.
OMERS Administration Corp first reported a position in ProKidney in Q2 2021 and held it in 4 quarters.
OMERS Administration Corp's ProKidney position peaked at $405K in Q2 2021.
71 funds tracked by Wall St. Rank held ProKidney as of Q2 2026.

Based on OMERS Administration Corp's 13F filing for Q2 2026, filed 13 Aug 2026.